Imperva Management Says Longer Sales Cycles To Blame For Poor Q2 Results

By: via Benzinga
Imperial Capital’s Michael Kim believes investors are likely to remain cautious on Imperva Inc (NYSE: IMPV) in the near term, ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.